New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 15, 2013
10:03 EDTDUK, GMCR, CVE, FTI, SYMC, VPHM, RPM, RAS, PDH, MLNX, MXIM, CS, CLF, CELG, BSXOn The Fly: Analyst Upgrade Summar
Today's noteworthy upgrades include: Boston Scientific (BSX) upgraded to Outperform from Neutral at Credit Suisse... Celgene (CELG) upgraded to Buy from Neutral at BofA/Merrill... Cliffs Natural (CLF) upgraded to Buy from Hold at Deutsche Bank... Credit Suisse (CS) upgraded to Outperform from Neutral at Exane BNP Paribas... Maxim Integrated (MXIM) upgraded to Outperform from Perform at Oppenheimer... Mellanox (MLNX) upgraded to Buy from Neutral at UBS... PetroLogistics (PDH) upgraded to Buy from Neutral at Citigroup... RAIT Financial (RAS) upgraded to Outperform from Market Perform at FBR Capital... RPM (RPM) upgraded to Perform from Underperform at Oppenheimer... ViroPharma (VPHM) upgraded to Buy from Neutral at BofA/Merrill... Symantec (SYMC) upgraded to Overweight from Equal Weight at Morgan Stanley... FMC Technologies (FTI) upgraded to Overweight from Equal Weight at Morgan Stanley... Cenovus Energy (CVE) upgraded to Overweight from Neutral at JPMorgan... Green Mountain (GMCR) upgraded to Buy from Hold at Argus... Duke Energy (DUK) upgraded to Buy from Neutral at UBS.
News For BSX;CELG;CLF;CS;MXIM;MLNX;PDH;RAS;RPM;VPHM;SYMC;FTI;CVE;GMCR;DUK From The Last 14 Days
Check below for free stories on BSX;CELG;CLF;CS;MXIM;MLNX;PDH;RAS;RPM;VPHM;SYMC;FTI;CVE;GMCR;DUK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 19, 2014
08:57 EDTDUKDuke Energy reports fuel oil spill into Ohio River
Subscribe for More Information
08:10 EDTFTIFMC Technologies awarded order by Petrobras
Subscribe for More Information
07:33 EDTCELGCelgene announces publication of REVLIMID combination results
Celgene announced that results of a study evaluating the combination of REVLIMID with rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate and prednisone in untreated diffuse large b-cell lymphoma were published online ahead of print in the Journal of Clinical Oncology. In a phase II, open label, single arm study, 64 patients with newly diagnosed, untreated, stage II-IV CD20 positive DLBCL received 25 mg of lenalidomide on days 1-10 with standard dose R-CHOP every 21 days for six cycles. All patients received pegfilgrastim on day two of each cycle and aspirin prophylaxis throughout. The primary endpoint was event-free survival with secondary endpoints of progression free survival and overall survival. A one-stage binomial design was used to assess the efficacy and tolerability of REVLIMID with R-CHOP. Of the 64 patients enrolled, 60 were eligible for response evaluation. In these patients, the overall response rate was 98% with 80% achieving a complete response. The 24-month EFS, which was identical to PFS, and OS rates were 59% and 78%, respectively. The company said, "This study demonstrated that the addition of lenalidomide to conventional R-CHOP resulted in similar PFS rates and OS rates between sub-types. This is intriguing as patients with the non-GCB phenotype have traditionally experienced poorer outcomes. The results of this study support further evaluation of this regimen in this sub-type of DLBCL.”
06:17 EDTSYMCSymantec turns attention to smartphones, connected devices, WSJ reports
Subscribe for More Information
05:14 EDTBSXBoston Scientific, ASAHI INTECC announce joint development programs
Subscribe for More Information
August 18, 2014
10:29 EDTMXIMGoldman cuts sector view on semiconductors to Cautious
Subscribe for More Information
10:01 EDTMXIMOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:04 EDTMXIMSemiconductors sector downgraded to Cautious from Neutral at Goldman
Goldman downgraded the Semiconductors sector to Cautious given signs the cycle is turning based on expectations for a slowdown in semiconductor revenue growth, above trend semi unit shipments that should normalize, and stretching lead times. As a result, the analyst sees risk to Q4 estimates and sees further downside of 10%-25% for the SOX (SOX) and downgraded NXP Semiconductors (NXPI) to Sell from Neutral, InvenSense (INVN) to Neutral from Buy, and removed Maxim Integrated (MXIM) from the Conviction Buy List.
07:48 EDTMXIMMaxim Integrated downgraded to Buy from Conviction Buy at Goldman
Subscribe for More Information
August 17, 2014
13:30 EDTCSCredit Suisse played role in Banco Espírito Santo demise, WSJ says
Subscribe for More Information
August 15, 2014
12:16 EDTGMCRMonster surges as Coca-Cola takes 16.7% stake in company
Subscribe for More Information
08:36 EDTCLFCliffs pays $11M to Halverson in connection with employment termination
Subscribe for More Information
August 14, 2014
07:39 EDTGMCRKeurig Green Mountain estimates lowered well below consensus at SunTrust
SunTrust lowered forecasts well below consensus for Keurig Green Mountain, as the firm believes its gross margins will be impacted by higher green coffee costs and new product launches. The firm's FY15 EPS estimate goes to $3.70 from $4.00, vs. consensus of $4.05, and FY16 was lowered to $4.39 from $4.49. When the company reports Q4 result in November, the analyst expects the company to provide FY15 guidance around its new estimate and for Street estimates to move lower. Shares are Neutral rated with a lowered price target of $110, down from $115.
07:07 EDTGMCRKeurig Green Mountain announces price increase, effective November 3
Subscribe for More Information
August 13, 2014
12:22 EDTCLFIron ore prices at lowest level in months, Business Spectator says
Subscribe for More Information
10:01 EDTSYMCOn The Fly: Analyst Initiation Summary
Subscribe for More Information
August 12, 2014
16:27 EDTSYMCSymantec initiated with a Neutral at Piper Jaffray
Target $26.
08:27 EDTMXIMMorgan Stanley remains positive on Semiconductor industry conditions
Subscribe for More Information
August 11, 2014
15:24 EDTSYMCBloomberg to hold a summit
Silicon Valley 2014 Cybersecurity Summit to be held in Palo Alto, California on August 12.
11:04 EDTBSXActive equity options trading on open
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use